SCHEMBL290992

SCHEMBL290992

CC1CCC(C(C)C)C(C(=O)Nc2ccccn2)C1

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 5/20 0.60
RAB9A P51151 3/20 0.53
LMNA P02545 2/20 0.53
ALDH1A1 P00352 2/20 0.51
MEN1 O00255 1/20 0.51
GAA P10253 1/20 0.51
KMT2A Q03164 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
EPHX1 P07099 1/20 0.46
POLB P06746 1/20 0.44
NPC1 O15118 2/20 0.43
PKM P14618 1/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12172893 0.84 RAB9A (0.50) RAB9ALMNAMEN1GAAKMT2A
SCHEMBL12189537 0.83 RAB9A (0.52) RAB9ALMNAALDH1A1GAANPC1
SCHEMBL4949094 0.81 TRPM8 (0.55) TRPM8LMNAALDH1A1SMN1; SMN2POLB
SCHEMBL10073491 0.81 TRPM8 (0.73) TRPM8RAB9AMEN1GAAKMT2A
SCHEMBL4817890 0.81 TRPM8 (0.73) TRPM8RAB9AMEN1GAAKMT2A
SCHEMBL10352434 0.79 RAB9A (0.59) RAB9ALMNAALDH1A1SMN1; SMN2POLB
SCHEMBL10352592 0.79 RAB9A (0.53) RAB9ALMNAALDH1A1GAANPC1
SCHEMBL10352879 0.79 RAB9A (0.58) RAB9AALDH1A1MEN1GAAKMT2A
SCHEMBL4629846 0.79 TRPM8 (0.70) TRPM8LMNAALDH1A1GAASMN1; SMN2
SCHEMBL23062653 0.78 TRPM8 (0.52) TRPM8RAB9ALMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664261-B2 Organic compounds having cooling properties GIVAUDAN S.A. (CH) 2014-03-04 US claimed
US-8377422-B2 Carboxamide derivatives having cooling properties GIVAUDAN S.A. (CH) 2013-02-19 US claimed
US-20120095042-A1 Organic Compounds Having Cooling Properties GIVAUDAN SA (CH) 2012-04-19 US claimed
EP-2427170-A2 ORGANIC COMPOUNDS HAVING COOLING PROPERTIES Givaudan SA (CH) 2012-03-14 EP claimed
US-20110182833-A1 Carboxamide Derivatives Having Cooling Properties GIVAUDAN SA (CH) 2011-07-28 US claimed
US-20100297038-A1 Benzimidazole Derivatives And Their Use As Cooling Agents GIVAUDAN S.A. (CH) 2010-11-25 US claimed
EP-2250154-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS COOLING AGENTS Givaudan SA (CH) 2010-11-17 EP claimed
WO-2010128026-A2 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2010-11-11 WO claimed
EP-2229352-A2 CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES Givaudan SA (CH) 2010-09-22 EP claimed
WO-2009089641-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS COOLING AGENTS GIVAUDAN SA (CH) 2009-07-23 WO claimed
WO-2009070910-A2 CARBOXAMIDE DERIVATIEVES HAVING COOLING PROPERTIES GIVAUDAN SA (CH) 2009-06-11 WO claimed
EP-2296759-B1 COOLING COMPOSITION GIVAUDAN SA (CH) 2019-10-02 EP disclosed
US-8664261-B2 Organic compounds having cooling properties GIVAUDAN S.A. (CH) 2014-03-04 US disclosed
US-8377422-B2 Carboxamide derivatives having cooling properties GIVAUDAN S.A. (CH) 2013-02-19 US disclosed
US-8288441-B2 Compositions comprising a physiological coolant GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2012-10-16 US disclosed
WO-2009140783-A1 COOLING COMPOSITION GIVAUDAN SA (CH) 2009-11-26 WO disclosed
WO-2009089641-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS COOLING AGENTS GIVAUDAN SA (CH) 2009-07-23 WO disclosed
WO-2009070910-A2 CARBOXAMIDE DERIVATIEVES HAVING COOLING PROPERTIES GIVAUDAN SA (CH) 2009-06-11 WO disclosed
WO-2008107137-A2 COMPOSITIONS COMPRISING A PHYSIOLOGICAL COOLANT GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2008-09-12 WO disclosed
US-20050187211-A1 N-arylsalkyl-carboxamide compositions and methods WEI EDWARD T (US) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297038-A1 Benzimidazole Derivatives And Their Use As Cooling Agents OR10J3, H1-3, ORC3 TRPM8 2049/4885RAB9A 3464/4885LMNA 1041/4885
US-20050187211-A1 N-arylsalkyl-carboxamide compositions and methods OPRL1, TRPV1, TRPA1 TRPM8 13/4885RAB9A 2610/4885LMNA 3939/4885
US-20110182833-A1 Carboxamide Derivatives Having Cooling Properties CPS1, NQO2, NDUFA2 TRPM8 376/4885RAB9A 2168/4885LMNA 1525/4885
US-20120095042-A1 Organic Compounds Having Cooling Properties ME3, ME2, MSMO1 TRPM8 361/4885RAB9A 3627/4885LMNA 3644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.